[Industry Voice #29] QL Biopharm's Vision for the Future of Chronic Metabolic Diseases 

In our new #IndustryVoice video podcast episode, join OCT Clinical in discussing the future of chronic metabolic diseases alongside QL Biopharm, a pioneering drug manufacturing company from China. Discover the cutting-edge insights and innovative strategies that QL Biopharm brings to the table, aiming to transform the landscape of chronic metabolic diseases and pharma market in China and around the globe.
0:40 - Introduction
1:04 - Future Developments in the Field of Metabolic Diseases
2:30 - Opportunities in the International Markets
3:06 - QL Biopharm's CRO Selection Criteria
4:08 - Corporate Strategies to Stay Up to date in the Industry.
Enjoy and subscribe to our RU-vid channel to be the first to know about new content on clinical research.
Webpage: oct-clinicaltr....
Experience: oct-clinicaltr....
Blog, articles, case studies: oct-clinicaltr....
LinkedIn: / oct-clinical-trials-in...
✉Reach out to become the next speaker: pr@oct-clinicaltrials.com
✉Submit an RFP for clinical services: info@oct-clinicaltrials.com
#cro #octclinical #chronicmetabolicdiseases #pharmaindustry #china #innovativetherapies #代谢性疾病 #中国 #qlbiopharm #质肽生物